Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review

November 2021 | 36 pages | ID: F62366B6A49EN
GlobalData

Abstracts

Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fidson Healthcare Plc (Fidson) develops, manufactures and distributes prescription and over the counter (OTC) pharmaceutical products. The company offers various drug products and formulations for various therapeutic categories, namely, anti-infectives, cardio-vascular, anti-malaria, anti-fungal, antacid and antiulcer, cardiovascular, gastrointestinal, anxiety medicines, antidepressants, cough, cold, catarrh, allergies, multivitamins, herbal supplements, anti-osteoarthritis and pain-relievers, among others. Its major products include antacid suspension classic, ctuxil, paracetamol, iprofloxacin, amino acid intravenous nutritional supplement, fluoxetine and olanzapine. It markets products under brand names such as Gascol, Meprasil, Biosulin, Peflotab, Ciprotab, Cutenox and Peflotab, among others. Fidson has its manufacturing facility in Sango-Ota, Ogun State. Fidson is headquartered in Lagos, Nigeria.

Fidson Healthcare Plc Key Recent Developments

Jan 18,2021: Fidson appoints new directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Fidson Healthcare Plc - Key Facts
Fidson Healthcare Plc - Key Employees
Fidson Healthcare Plc - Key Employee Biographies
Fidson Healthcare Plc - Major Products and Services
Fidson Healthcare Plc - History
Fidson Healthcare Plc - Company Statement
Fidson Healthcare Plc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Fidson Healthcare Plc - Business Description
Business Segment: Consumer Products Segment
Overview
Performance
Business Segment: Ethical Products Segment
Overview
Performance
Business Segment: Over the Counter Segment
Overview
Performance
Fidson Healthcare Plc - Corporate Strategy
Fidson Healthcare Plc - SWOT Analysis
SWOT Analysis - Overview
Fidson Healthcare Plc - Strengths
Fidson Healthcare Plc - Weaknesses
Fidson Healthcare Plc - Opportunities
Fidson Healthcare Plc - Threats
Fidson Healthcare Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fidson Healthcare Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jan 18, 2021: Fidson appoints new directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Fidson Healthcare Plc, Key Facts
Fidson Healthcare Plc, Key Employees
Fidson Healthcare Plc, Key Employee Biographies
Fidson Healthcare Plc, Major Products and Services
Fidson Healthcare Plc, History
Fidson Healthcare Plc, Key Competitors
Fidson Healthcare Plc, Ratios based on current share price
Fidson Healthcare Plc, Annual Ratios
Fidson Healthcare Plc, Annual Ratios (Cont...1)
Fidson Healthcare Plc, Annual Ratios (Cont...2)
Fidson Healthcare Plc, Interim Ratios
Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fidson Healthcare Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Fidson Healthcare Plc, Performance Chart (2016 - 2020)
Fidson Healthcare Plc, Ratio Charts
Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021